Avacopan is also in late-stage clinical development for the treatment of Hidradenitis Suppurativa and C3 glomerulopathy (C3G). ChemoCentryx also …
Source link
Related
https://higenix.com/wp-content/uploads/2021/01/99749a921dca8daa5f0424fd5190789a
131
210
Steve
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png
Steve2021-01-07 05:52:422021-01-07 05:52:42ChemoCentryx to Participate in Two Upcoming Investor Conferences
Leave a Reply
Want to join the discussion?Feel free to contribute!